Biorce

What They Do

AI-driven clinical trials platform accelerating drug development. Uses machine learning to optimize trial design, patient recruitment, and protocol optimization.

Funding

Valuation: ~€200M implied ($52.5M Series A, 2025) €43.8M Series A (2025)

See Also

• Spain
• AI Clinical Trials